Hausman Diana
Former Chief Medical Officer at ZNTL; Chief Medical Officer at Zymeworks Inc.
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 5
- Latest May 9, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ZNTLZentalis Pharmaceuticals, Inc.Former Chief Medical Officer
- Zymeworks Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Zymeworks Inc.66,048 shares
- ZNTL3,356 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Zymeworks Inc.UnusualSep 14, 2020 2020
Sold 40,000 shares at $45.00 ($1.8M)
Hausman Diana, Chief Medical Officer
Sold 91.5% of holdings ($2M position)3,718 shares leftFirst sale on recordFiling
- 2 Form 4 sale Zymeworks Inc.UnusualDec 2, 2020 +79 days
Sold 18,968 shares at $55.18 ($1M)
Hausman Diana, Chief Medical Officer
Sold 83.6% of holdings ($1.3M position)3,718 shares leftFiling
- 3 Form 4 sale Zymeworks Inc.UnusualDec 4, 2020 +2 days
Sold 6,032 shares at $55.12 ($332k)
Hausman Diana, Chief Medical Officer
Sold 61.9% of holdings ($537k position)3,718 shares leftFiling
- 4 Form 4 sale Zymeworks Inc.Plan not statedMar 10, 2021 +96 days
Sold 1,048 shares at $34.95 ($37k)
Hausman Diana, Chief Medical Officer
Sold 16.3% of holdings ($225k position)5,377 shares left0.1x usual sizeFiling
- 5 Form 4 sale ZNTLNo planMay 9, 2024 +1156 days
Sold 3,356 shares at $12.62 ($42k)
Hausman Diana, Chief Medical Officer
No 10b5-1 planSold 0.9% of holdings ($4.8M position)373,876 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice ZNTLNoticeMay 9, 2024 same day
Filed to sell 3,356 shares ($42k)
Hausman Diana, Chief Medical Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice ZNTLNoticeOct 31, 2024 +175 days
Filed to sell 9,888 shares ($28k)
Hausman Diana, Former Chief Medical Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | Oct 31, 2024 | ZNTL | Former Chief Medical Officer | Form 144 notice | 9,888 | $28k | Notice | SEC | |
| May 9, 2024 | May 9, 2024 | ZNTL | Chief Medical Officer | Form 144 notice | 3,356 | $42k | Notice | SEC | |
| May 9, 2024 | May 9, 2024 | ZNTL | Chief Medical Officer | Form 4 sale | 3,356 | $42k | 0.9% | No plan | SEC |
| Mar 10, 2021 | Mar 12, 2021 | Zymeworks Inc. | Chief Medical Officer | Form 4 sale | 1,048 | $37k | 16.3% | Plan not stated | SEC |
| Dec 4, 2020 | Dec 4, 2020 | Zymeworks Inc. | Chief Medical Officer | Form 4 sale | 6,032 | $332k | 61.9% | Unusual | SEC |
| Dec 2, 2020 | Dec 3, 2020 | Zymeworks Inc. | Chief Medical Officer | Form 4 sale | 18,968 | $1M | 83.6% | Unusual | SEC |
| Sep 14, 2020 | Sep 16, 2020 | Zymeworks Inc. | Chief Medical Officer | Form 4 sale | 40,000 | $1.8M | 91.5% | Unusual | SEC |